SecBot SecBot
144 ·Filed May 13, 2026

APGE

Apogee Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago SEC0001949846-26-000273
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine director sale tied to RSU vesting, not a C-suite exit. No material bearish signal. Monitor for actual Form 4 filings to confirm execution, but no immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$83.94
T+0 close · May 13, 2026 · via day close
Latest settled
+60.64%
T+60 · $134.84
Vs SPY
+56.20%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 13 $83.94entry
  2. T+1 · 6mo ago −0.04%α −0.81% · $83.91
  3. T+5 · 6mo ago −3.04%α −2.90% · $81.39
  4. T+20 · 5mo ago +6.62%α +7.24% · $89.50
  5. T+60 · 3mo ago +60.64%α +56.20% · $134.84
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Michael Thomas Henderson filed a Form 144 on May 13, 2026, indicating intent to sell 60,000 shares of Apogee Therapeutics common stock, with an approximate market value of $4.95 million based on the filing date price. This is a routine insider sale by a director, not a C-suite officer, and the shares appear to originate from RSU vesting, reducing its signaling significance.

Key Facts

  • Director Michael Thomas Henderson filed Form 144 to sell 60,000 shares.
  • Estimated sale value ~$4.95 million based on filing date market price.
  • Shares acquired via RSU vesting from October 2023 through January 2024.
  • Henderson is a director, not CEO/CFO, reducing insider signal weight.
  • Recent insider activity (30d) shows 3 sells totaling $556K, all small relative to market cap.
  • Company market cap is $6.2B; the proposed sale represents ~0.08% of shares outstanding.

Financial Impact

Proposed sale of 60,000 shares valued at ~$4.95 million, representing a small fraction of market cap.

dilution

Risk Factors

  • Insider sale could be misinterpreted as negative signal by the market.
  • If additional large insider sales follow, sentiment could shift.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
83% bullish (23 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001949846-26-000273
Document: 0001949846-26-000273-index.html0001949846-26-000273
Document: 0001949846-26-000273.txt0001949846-26-000273

Track record

31 reports on APGE

Performance horizon

9 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +73.31% at T+60 after the May 27, 2026 report. 12 of 13 went positive at some point.

Filters
  1. Sep 14, 20269w ago 15-12G Neutral 4/10 No price data
  2. Sep 3, 202610w ago 25-NSE Bullish 8/10 Entry $135.06 No price data
  3. Sep 3, 202610w ago 8-K Bullish 8/10 Entry $135.06 No price data
  4. Aug 11, 202613w ago 8-K Bullish 7/10 Entry $134.55 No price data
  5. Aug 10, 202614w ago 8-K Bullish 8/10 No price data
  6. Aug 10, 202614w ago Press Release Bullish 8/10 Entry $134.65 No price data
  7. Aug 6, 202614w ago Institutional Cluster Mixed 5/10 Entry $134.49 to $135.07 ▲ +0.43% −0.17% vs SPY
  8. Aug 3, 202615w ago DEFA14A Bullish 5/10 Entry $134.19 to $135.08 ▲ +0.66% +1.90% vs SPY
  9. Jul 10, 202618w ago Insider Cluster Neutral 2/10 Entry $133.82 to $134.65 ▲ +0.62% −2.56% vs SPY
  10. Jun 26, 202620w ago DEFA14A Bullish 6/10 Entry $132.61 to $134.28 ▲ +1.26% +1.54% vs SPY
Showing 10 of 31

US Market Status

Market Closed · Opens Wed (10h 8m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 13, 2026